Infinium Pharmachem Limited

NSEI:INFINIUM Stock Report

Market Cap: ₹3.5b

Infinium Pharmachem Management

Management criteria checks 4/4

Infinium Pharmachem's CEO is Sanjaykumar Patel, appointed in Oct 2022, has a tenure of 3.25 years. directly owns 10.25% of the company’s shares, worth ₹359.55M. The average tenure of the management team and the board of directors is 9.2 years and 9.2 years respectively.

Key information

Sanjaykumar Patel

Chief executive officer

₹5.0m

Total compensation

CEO salary percentagen/a
CEO tenure3.3yrs
CEO ownership10.3%
Management average tenure9.2yrs
Board average tenure9.2yrs

Recent management updates

Recent updates

Shaky Earnings May Not Tell The Whole Story For Infinium Pharmachem (NSE:INFINIUM)

Nov 21
Shaky Earnings May Not Tell The Whole Story For Infinium Pharmachem (NSE:INFINIUM)

Is Infinium Pharmachem (NSE:INFINIUM) Using Too Much Debt?

Feb 12
Is Infinium Pharmachem (NSE:INFINIUM) Using Too Much Debt?

Investors Still Aren't Entirely Convinced By Infinium Pharmachem Limited's (NSE:INFINIUM) Earnings Despite 38% Price Jump

Sep 20
Investors Still Aren't Entirely Convinced By Infinium Pharmachem Limited's (NSE:INFINIUM) Earnings Despite 38% Price Jump

Many Still Looking Away From Infinium Pharmachem Limited (NSE:INFINIUM)

Aug 04
Many Still Looking Away From Infinium Pharmachem Limited (NSE:INFINIUM)

Infinium Pharmachem (NSE:INFINIUM) Strong Profits May Be Masking Some Underlying Issues

Jun 12
Infinium Pharmachem (NSE:INFINIUM) Strong Profits May Be Masking Some Underlying Issues

Infinium Pharmachem (NSE:INFINIUM) Strong Profits May Be Masking Some Underlying Issues

Nov 06
Infinium Pharmachem (NSE:INFINIUM) Strong Profits May Be Masking Some Underlying Issues

CEO

Sanjaykumar Patel (46 yo)

3.3yrs
Tenure
₹4,950,000
Compensation

Mr. Sanjaykumar Viththalbhai Patel serves as Chairman and Managing Director of Infinium Pharmachem Private Limited since October 14, 2022. He serves as Director of Infinium Pharmachem Private Limited since...


Leadership Team

NamePositionTenureCompensationOwnership
Sanjaykumar Patel
Chairman & MD3.3yrs₹4.95m10.25%
₹ 359.6m
Nilesh Dharamshi Patel
CFO, Company Secretary and Compliance Officer2.2yrs₹3.55mno data
Pravin Madhani
Whole Time Director22.2yrs₹4.95m29.14%
₹ 1.0b
Mitesh Chikhaliya
Whole Time Director15.2yrs₹4.95m12.38%
₹ 434.1m
9.2yrs
Average Tenure
46yo
Average Age

Experienced Management: INFINIUM's management team is seasoned and experienced (9.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Sanjaykumar Patel
Chairman & MD22.2yrs₹4.95m10.25%
₹ 359.6m
Pravin Madhani
Whole Time Director22.2yrs₹4.95m29.14%
₹ 1.0b
Mitesh Chikhaliya
Whole Time Director15.2yrs₹4.95m12.38%
₹ 434.1m
Keyur Shah
Non-Executive Independent Director3.3yrs₹20.00kno data
Tarun Dobariya
Non-Executive Independent Director3.3yrs₹20.00kno data
Vaishakhi Shukla
Non-Executive Independent Director3.3yrs₹20.00kno data
9.2yrs
Average Tenure
45.5yo
Average Age

Experienced Board: INFINIUM's board of directors are considered experienced (9.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/18 09:19
End of Day Share Price 2026/01/16 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Infinium Pharmachem Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.